Hypoxia‐inducible factor 1 alpha (HIF‐1α) stimulated and P2X7 receptor activated by COVID-19, as a potential therapeutic target and risk factor for epilepsy
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hypoxia‐inducible factor 1 alpha (HIF‐1α) stimulated and P2X7 receptor activated by COVID-19, as a potential therapeutic target and risk factor for epilepsy
Authors
Keywords
-
Journal
Human Cell
Volume 35, Issue 5, Pages 1338-1345
Publisher
Springer Science and Business Media LLC
Online
2022-07-14
DOI
10.1007/s13577-022-00747-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The role of polyphenols in overcoming cancer drug resistance: a comprehensive review
- (2022) Parisa Maleki Dana et al. CELLULAR & MOLECULAR BIOLOGY LETTERS
- Beyond Seizure Control: Treating Comorbidities in Epilepsy via Targeting of the P2X7 Receptor
- (2022) Beatriz Gil et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Role of Purinergic P2X7 Receptor in Inflammation and Cancer: Novel Molecular Insights and Clinical Applications
- (2022) John Charles Rotondo et al. Cancers
- Lectins and lectibodies: potential promising antiviral agents
- (2022) Mohsen Nabi-Afjadi et al. CELLULAR & MOLECULAR BIOLOGY LETTERS
- Quercetin potential effects against SARS‐CoV ‐2 infection and COVID ‐19‐associated cancer progression by inhibiting mTOR and hypoxia‐inducible factor‐1α ( HIF ‐1α)
- (2022) Hamidreza Zalpoor et al. PHYTOTHERAPY RESEARCH
- Flt3-ITD mutated acute myeloid leukemia patients and COVID-19: potential roles of autophagy and HIF-1α in leukemia progression and mortality
- (2022) Hamidreza Zalpoor et al. Human Cell
- Ephrin (Eph) receptor and downstream signaling pathways: a promising potential targeted therapy for COVID‑19 and associated cancers and diseases
- (2022) Hamidreza Zalpoor et al. Human Cell
- Increased neuropilin-1 expression by COVID-19: a possible cause of long-term neurological complications and progression of primary brain tumors
- (2022) Hamidreza Zalpoor et al. Human Cell
- Effects of Cell Proteostasis Network on the Survival of SARS-CoV-2
- (2021) Fateme Khomari et al. BIOLOGICAL PROCEDURES ONLINE
- Antagonism of the ATP-gated P2X7 receptor: a potential therapeutic strategy for cancer
- (2021) Matthew Drill et al. Purinergic Signalling
- Different T cell related immunological profiles in COVID-19 patients compared to healthy controls
- (2021) Armin Mahmoud Salehi Khesht et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- ATP and adenosine—Two players in the control of seizures and epilepsy development
- (2021) Edward Beamer et al. PROGRESS IN NEUROBIOLOGY
- The effect of vitamin D, magnesium and zinc supplements on interferon signaling pathways and their relationship to control SARS-CoV-2 infection
- (2021) Mohsen Nabi-Afjadi et al. Clinical and Molecular Allergy
- P2X7 receptor‐targeted regulation by tetrahydroxystilbene glucoside in alcoholic hepatosteatosis: A new strategy towards macrophage–hepatocyte crosstalk
- (2020) Yu Zhang et al. BRITISH JOURNAL OF PHARMACOLOGY
- A rationale for targeting the P2X7 receptor in Coronavirus disease 19 (Covid‐19)
- (2020) Francesco Di Virgilio et al. BRITISH JOURNAL OF PHARMACOLOGY
- New onset acute symptomatic seizure and risk factors in coronavirus disease 2019: A retrospective multicenter study
- (2020) Lu Lu et al. EPILEPSIA
- Interplay between Liver X Receptor and Hypoxia Inducible Factor 1α Potentiates Interleukin-1β Production in Human Macrophages
- (2020) Louise Ménégaut et al. Cell Reports
- Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China
- (2020) Ling Mao et al. JAMA Neurology
- Acute encephalopathy with elevated CSF inflammatory markers as the initial presentation of COVID-19
- (2020) Shelli Farhadian et al. BMC Neurology
- Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis
- (2020) Ana Campos Codo et al. Cell Metabolism
- Epilepsy and COVID-19: Associations and important considerations
- (2020) Naoto Kuroda EPILEPSY & BEHAVIOR
- EEG Findings in Coronavirus Disease
- (2020) Madison S. Pilato et al. JOURNAL OF CLINICAL NEUROPHYSIOLOGY
- First case of focal epilepsy associated with SARS‐coronavirus‐2
- (2020) Sara Elgamasy et al. JOURNAL OF MEDICAL VIROLOGY
- The purinergic P2X7 receptor as a potential drug target to combat neuroinflammation in neurodegenerative diseases
- (2020) Francesco Calzaferri et al. MEDICINAL RESEARCH REVIEWS
- Seizures associated with coronavirus infections
- (2020) Ali A. Asadi-Pooya SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Seizure with CSF lymphocytosis as a presenting feature of COVID-19 in an otherwise healthy young man
- (2020) Shane Lyons et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Epilepsy in time of COVID‐19: A survey‐based study
- (2020) Elena Fonseca et al. ACTA NEUROLOGICA SCANDINAVICA
- Did the COVID-19 pandemic silence the needs of people with epilepsy?
- (2020) Tiziana Granata et al. EPILEPTIC DISORDERS
- Neonatal Seizures and Purinergic Signalling
- (2020) Aida Menéndez Méndez et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The potential involvement of P2X7 receptor in COVID‐19 pathogenesis: a new therapeutic target?
- (2020) Paulo A F Pacheco et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- The immunology of SARS-CoV-2 infection, the potential antibody based treatments and vaccination strategies
- (2020) Zahra Payandeh et al. Expert Review of Anti-Infective Therapy
- Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology
- (2020) Deidiane Elisa Ribeiro et al. MOLECULAR PSYCHIATRY
- COVID-19, de novo seizures, and epilepsy: a systematic review
- (2020) Ali A. Asadi-Pooya et al. NEUROLOGICAL SCIENCES
- ATP Release During Seizures – A Critical Evaluation of the Evidence
- (2019) Edward Beamer et al. BRAIN RESEARCH BULLETIN
- A Mechanism-Based Approach to P2X7 Receptor Action
- (2019) Mehmet Ugur et al. MOLECULAR PHARMACOLOGY
- CCR7 Chemokine Receptor-Inducible lnc-Dpf3 Restrains Dendritic Cell Migration by Inhibiting HIF-1α-Mediated Glycolysis
- (2019) Juan Liu et al. IMMUNITY
- P2X7 receptor induces mitochondrial failure in monocytes and compromises NLRP3 inflammasome activation during sepsis
- (2019) Juan José Martínez-García et al. Nature Communications
- Pyroglutamide-Based P2X7 Receptor Antagonists Targeting Inflammatory Bowel Disease
- (2019) Germain Homerin et al. JOURNAL OF MEDICINAL CHEMISTRY
- Astrocytes and ischemic tolerance
- (2018) Yuri Hirayama et al. NEUROSCIENCE RESEARCH
- The P2X7 Receptor in Infection and Inflammation
- (2017) Francesco Di Virgilio et al. IMMUNITY
- Effects of P2X7 receptor antagonists on hypoxia-induced neonatal seizures in mice
- (2017) Natalia Rodriguez-Alvarez et al. NEUROPHARMACOLOGY
- Inhibiting HIF-1α Decreases Expression of TNF-α and Caspase-3 in Specific Brain Regions Exposed Kainic Acid-Induced Status Epilepticus
- (2016) Jixue Yang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Coronavirus Infections in the Central Nervous System and Respiratory Tract Show Distinct Features in Hospitalized Children
- (2016) Yuanyuan Li et al. INTERVIROLOGY
- Prevalence and incidence of epilepsy
- (2016) Kirsten M. Fiest et al. NEUROLOGY
- Infections, inflammation and epilepsy
- (2015) Annamaria Vezzani et al. ACTA NEUROPATHOLOGICA
- Expression levels of microRNA-199 and hypoxia-inducible factor-1 alpha in brain tissue of patients with intractable epilepsy
- (2015) Guohui Jiang et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- The P2X7 receptor is a key modulator of the PI3K/GSK3β/VEGF signaling network: evidence in experimental neuroblastoma
- (2015) F Amoroso et al. ONCOGENE
- Hypoxia inducible factor-1α expression is associated with hippocampal apoptosis during epileptogenesis
- (2014) Qianfa Long et al. BRAIN RESEARCH
- Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia
- (2014) Mustafa Saad et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- P2X7 receptor: an emerging target in central nervous system diseases
- (2014) Beáta Sperlágh et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Extracellular ATP induces cell death in human intestinal epithelial cells
- (2012) Carolina O. Souza et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Investigation of hypoxia-inducible factor-1α in hippocampal sclerosis: A postmortem study
- (2012) Alexandra Feast et al. EPILEPSIA
- Hypoxia Markers are Expressed in Interneurons Exposed to Recurrent Seizures
- (2012) Fabio Gualtieri et al. NEUROMOLECULAR MEDICINE
- Genetics of Epilepsy
- (2012) Massimo Pandolfo SEMINARS IN NEUROLOGY
- The P2X7 receptor is a key modulator of aerobic glycolysis
- (2012) F Amoroso et al. Cell Death & Disease
- Hypoxia-increased RAGE and P2X7R expression regulates tumor cell invasion through phosphorylation of Erk1/2 and Akt and nuclear translocation of NF-κB
- (2011) Marco Tafani et al. CARCINOGENESIS
- Seizure suppression and neuroprotection by targeting the purinergic P2X7 receptor during status epilepticus in mice
- (2011) Tobias Engel et al. FASEB JOURNAL
- Extracellular ATP Is a Danger Signal Activating P2X7Receptor in Lung Inflammation and Fibrosis
- (2010) Nicolas Riteau et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Epileptic seizures: Quakes of the brain?
- (2010) Ivan Osorio et al. PHYSICAL REVIEW E
- Mitochondria, oxidative stress, and temporal lobe epilepsy
- (2009) Simon Waldbaum et al. EPILEPSY RESEARCH
- Alteration of purinergic P2X4 and P2X7 receptor expression in rats with temporal-lobe epilepsy induced by pilocarpine
- (2008) Flavia Doná et al. EPILEPSY RESEARCH
- Mitochondrial DNA damage and impaired base excision repair during epileptogenesis
- (2008) Stuart G. Jarrett et al. NEUROBIOLOGY OF DISEASE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started